CG
IPXL

Cutler Group’s Impax Laboratories, Inc. IPXL Stock Holding History

Cutler Group’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,600
Closed -$8K – 7591
2017
Q1 		$8K Buy
+1,600
New +$19.3K ﹤0.01% 4341
2016
Q3 		– Sell
-2,600
Closed -$3K – 7808
2016
Q2 		$3K Buy
+2,600
New +$84.7K ﹤0.01% 5524
2016
Q1 		– Sell
-1,900
Closed -$2K – 7636
2015
Q4 		$2K Buy
+1,900
New +$75.9K ﹤0.01% 5759

Other funds holding IPXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TG
TCW Group Los Angeles, California $13.3B AUM 34.44% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Cutler Group's IPXL Position: Q4 2017 in Review

Cutler Group sold out of Impax Laboratories, Inc. (IPXL) in Q4 2017, closing a stake of 400 shares — an estimated $8K sold.

Cutler Group first reported a position in IPXL in Q2 2016 and held it in 6 quarters. The position peaked at $116K in Q4 2016. 200 funds tracked by Wall St. Rank hold IPXL as of Q4 2017.

  • Cutler Group reported no remaining Impax Laboratories, Inc. position as of Q4 2017 after selling out during the quarter.
  • Cutler Group sold 400 Impax Laboratories, Inc. shares in Q4 2017, an estimated $8K.
  • Cutler Group first reported a position in Impax Laboratories, Inc. in Q2 2016 and held it in 6 quarters.
  • Cutler Group's Impax Laboratories, Inc. position peaked at $116K in Q4 2016.
  • 200 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q4 2017.

Based on Cutler Group's 13F filing for Q4 2017, filed 17 Jan 2018.